AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Indivior Pharmaceuticals Inc. (INDV)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.18 −0.36%
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
AMNEAL PHARMACEUTICALS, INC. and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. is the larger, with a market value of $6.2B against $4.0B — 1.5× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 11.2× against 38.4×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 13.5% against 9.28%. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs 5.05%) and the higher return on invested capital (460.5% vs 11.1%). Across the 20 metrics below, Indivior Pharmaceuticals Inc. leads on 15 and AMNEAL PHARMACEUTICALS, INC. on 5.
Valuation
Profitability
| Metric | AMRX | INDV | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 39.32% | 81.97% | 53.94% |
| Operating margin | 14.56% | 31.56% | 0.00% |
| Net margin | 5.05% | 26.75% | 0.00% |
| Free cash flow margin | (0.37%) | (8.34%) | 0.00% |
| Return on equity | (395.84%) | (153.12%) | (0.40%) |
| Return on assets | 4.37% | 26.52% | (3.32%) |
| Return on invested capital | 11.05% | 460.53% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack